Goldman Sachs cuts General Mills stock rating, lowers price target

Goldman Sachs downgraded General Mills (GIS) to Neutral from Buy, citing limited near-term upside due to rising cost pressures and plans to reinvest potential gains in fiscal year 2026. The firm lowered its price target to $58 from $68, while the stock trades near its 52-week low with a 4.38% dividend yield. This downgrade coincides with other analyst revisions, including a price target cut from Citi and a Sell rating from UBS, as General Mills navigates sales challenges and a $130 million cost-reduction plan amid broader industry shifts like the FDA's phasing out of synthetic dyes.

Analysis

Goldman Sachs has downgraded General Mills (GIS) to Neutral from Buy, reducing its 12-month price target to $58 from $68, citing limited near-term upside potential due to rising cost pressures and the company's strategy to reinvest potential fiscal year 2026 gains to support top-line growth. This cautious outlook is shared by other analysts, with Citi lowering its price target to $56 and UBS initiating coverage with a Sell rating and a $54 target, highlighting concerns over sales challenges and financial headwinds. General Mills' stock currently trades near its 52-week low of $52.39, at an 11.95x earnings multiple, while offering a notable 4.38% dividend yield, underpinned by a 55-year history of consistent dividend payments. Despite this dividend stability, the company has reported a 2.62% decline in revenue over the last twelve months. While Goldman Sachs sees a potential return to a 2-3% long-term organic sales growth target by fiscal year 2027, they emphasize the need for further evidence of recovery and a more balanced risk/reward scenario. In response to these challenges, General Mills has announced a $130 million cost-reduction plan to be completed by fiscal 2028 and is strategically promoting Dana McNabb to oversee its North America Retail and Pet segments, indicating a focus on the growing pet food industry. The company also faces broader market shifts, such as the FDA's decision to phase out synthetic dyes, which will necessitate adjustments. The next earnings report is scheduled for June 25.

Key Decisions for Investors

• Investors should acknowledge the increased caution from analysts like Goldman Sachs, Citi, and UBS regarding General Mills' near-term growth prospects due to cost pressures and reinvestment plans, despite the stock trading near its 52-week low.
• The current 4.38% dividend yield, supported by a 55-year payment history, may offer appeal for income-focused investors, but this must be weighed against the recent 2.62% revenue decline and the uncertain timeline for a return to sustained organic sales growth.
• Closely monitor General Mills' upcoming earnings on June 25 and management's commentary on the effectiveness of its $130 million cost-reduction plan and strategies to navigate reinvestment in FY26 and industry-specific challenges like the synthetic dye phase-out before making significant portfolio adjustments.